Delivery Order SPE2DR25D3103-SPE2DR26F9T44
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,676.16 to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Zymfentra 120 mg/ml pen kits. This competitive contract represents a firm fixed-price delivery order with an ultimate completion date of December 31, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Zymfentra 120 mg/ml pen kits under a firm fixed-price contract with a ceiling value of $2,911.28. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of December 3, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $6,338.08 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Zymfentra 120 mg/ml pen kits with a completion date of January 7, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,584.52 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits on November 25, 2025, with an ultimate completion date of December 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The order represents a continuation of pharmaceutical supply services under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,584.52 firm fixed price delivery order on December 29, 2025, for Zymfentra 120 mg/ml pen kits, with a completion deadline of January 21, 2026. The contract was competitively awarded without set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $3,169.04 delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits under a firm fixed-price contract. The order, issued on December 31, 2025, with completion targeted for January 23, 2026, represents a non-set-aside competitive award to support federal medical procurement requirements. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania—the location of performance for this delivery order—is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Zymfentra 120 mg/ml pen kits, with a ceiling value of $1,584.52 and an ultimate completion date of December 24, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Zymfentra 120 mg/ml pen kits valued at $1,455.64. This is a firm fixed-price, non-competitive set-aside delivery order with an ultimate completion date of November 26, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Zymfentra 120 mg/ml pen kits, with a contract ceiling value of $1,503.56. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through open competition. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 7, 2025. This delivery...
- On November 26, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $3,169.04 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits, with a completion date of December 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9T44Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,753.56 to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Zymfentra 120 mg/ml pen kits, with an ultimate completion date of January 22, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies a comprehensive range of medications and medical supplies to military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism, enabling the contractor to supply specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 12/29/25 |